European Urology, 81(4), 337-346. ELSEVIER European Urology Willemse, P-P M, Davis, N F, Grivas, N, Zattoni, F, Lardas, M, Briers, E, Cumberbatch, M G, de Santis, M, Dell'Oglio, P, Donaldson, J F, Fossati, N, Gandaglia, G, Gillessen, S, Grummet, J P, Henry, A M, Liew, M, MacLennan, S, Mason, M D, Moris, L, Plass, K, O'Hanlon, S, Omar, M I, Oprea-Lager, D E, Pang, K H, Paterson, C C, Ploussard, G, Rouvière, O, Schoots, I G, Tilki, D, van den Bergh, R C N, van den Broeck, T, van der Kwast, T H, van der Poel, H G, Wiegel, T, Yuan, C Y, Cornford, P, Mottet, N & Lam, T B L 2022, ' Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy ', European Urology, vol. 81, no. 4, pp. 337-346 . https://doi.org/10.1016/j.eururo.2021.12.007
European Urology Oncology, 6, 2, pp. 214-221 Beijert, I J, Hentschel, A E, Bründl, J, Compérat, E M, Plass, K, Rodríguez, O, Subiela Henríquez, J D, Hernández, V, de la Peña, E, Alemany, I, Turturica, D, Pisano, F, Soria, F, Čapoun, O, Bauerová, L, Pešl, M, Bruins, H M, Runneboom, W, Herdegen, S, Breyer, J, Brisuda, A, Calatrava, A, Rubio-Briones, J, Seles, M, Mannweiler, S, Bosschieter, J, Kusuma, V R M, Ashabere, D, Huebner, N, Cotte, J, Mertens, L S, Claps, F, Masson-Lecomte, A, Liedberg, F, Cohen, D, Lunelli, L, Cussenot, O, el Sheikh, S, Volanis, D, Côté, J-F, Rouprêt, M, Haitel, A, Shariat, S F, Mostafid, A H, Nieuwenhuijzen, J A, Zigeuner, R, Dominguez-Escrig, J L, Hacek, J, Zlotta, A R, Burger, M, Evert, M, Hulsbergen-van de Kaa, C A, van der Heijden, A G, Kiemeney, L A L M, Soukup, V, Molinaro, L, Gontero, P, Llorente, C, Algaba, F, Palou, J, N'Dow, J, Ribal, M J, van der Kwast, T H, Babjuk, M, Sylvester, R J & van Rhijn, B W G 2023, ' Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum ', European Urology Oncology, vol. 6, no. 2, pp. 214-221 . https://doi.org/10.1016/j.euo.2023.01.004 European Urology Oncology, 6(2), 214-221. Elsevier BV
European Urology Focus, 8(6), 1627-1634. Elsevier BV Beijert, I J, Hentschel, A E, Bründl, J, Compérat, E M, Plass, K, Rodríguez, O, Subiela Henríquez, J D, Hernández, V, de la Peña, E, Alemany, I, Turturica, D, Pisano, F, Soria, F, Čapoun, O, Bauerová, L, Pešl, M, Maxim Bruins, H, Runneboom, W, Herdegen, S, Breyer, J, Brisuda, A, Calatrava, A, Rubio-Briones, J, Seles, M, Mannweiler, S, Bosschieter, J, Kusuma, V R M, Ashabere, D, Huebner, N, Cotte, J, Mertens, L S, Masson-Lecomte, A, Liedberg, F, Cohen, D, Lunelli, L, Cussenot, O, El Sheikh, S, Volanis, D, Côté, J-F, Rouprêt, M, Haitel, A, Shariat, S F, Mostafid, A H, Nieuwenhuijzen, J A, Zigeuner, R, Dominguez-Escrig, J L, Hacek, J, Zlotta, A R, Burger, M, Evert, M, Hulsbergen-van de Kaa, C A, van der Heijden, A G, A L M Kiemeney, L, Soukup, V, Molinaro, L, Gontero, P, Llorente, C, Algaba, F, Palou, J, N'Dow, J, Ribal, M J, van der Kwast, T H, Babjuk, M, Sylvester, R J & van Rhijn, B W G 2022, ' T1G1 Bladder Cancer : Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum ', European Urology Focus, vol. 8, no. 6, pp. 1627-1634 . https://doi.org/10.1016/j.euf.2022.04.014 European Urology Focus, 8, 1627-1634 European Urology Focus, 8, 6, pp. 1627-1634
Urologic Oncology-Seminars and Original Investigations, 38, 5, pp. 440-448 UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname Urologic Oncology-Seminars and Original Investigations, 38, 440-448 Hentschel, A E, van Rhijn, B W G, Bründl, J, Compérat, E M, Plass, K, Rodríguez, O, Henríquez, J D S, Hernández, V, de la Peña, E, Alemany, I, Turturica, D, Pisano, F, Soria, F, Čapoun, O, Bauerová, L, Pešl, M, Bruins, H M, Runneboom, W, Herdegen, S, Breyer, J, Brisuda, A, Scavarda-Lamberti, A, Calatrava, A, Rubio-Briones, J, Seles, M, Mannweiler, S, Bosschieter, J, Kusuma, V R M, Ashabere, D, Huebner, N, Cotte, J, Mertens, L S, Cohen, D, Lunelli, L, Cussenot, O, Sheikh, S E, Volanis, D, Coté, J-F, Rouprêt, M, Haitel, A, Shariat, S F, Mostafid, A H, Nieuwenhuijzen, J A, Zigeuner, R, Dominguez-Escrig, J L, Hacek, J, Zlotta, A R, Burger, M, Evert, M, Hulsbergen-van de Kaa, C A, van der Heijden, A G, Kiemeney, L A L M, Soukup, V, Molinaro, L, Gontero, P, Llorente, C, Algaba, F, Palou, J, N'Dow, J, Babjuk, M, van der Kwast, T H & Sylvester, R J 2020, ' Papillary urothelial neoplasm of low malignant potential (PUN-LMP) : Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019? ', Urologic Oncology, vol. 38, no. 5, doi: 10.1016/j.urolonc.2019.10.002, pp. 440-448 . https://doi.org/10.1016/j.urolonc.2019.10.002 Urologic Oncology, 38(5):doi: 10.1016/j.urolonc.2019.10.002, 440-448. Elsevier Inc.